These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 34807508)

  • 1. 2',3'-Cyclic GMP-AMP Dinucleotides for STING-Mediated Immune Modulation: Principles, Immunotherapeutic Potential, and Synthesis.
    Shang M; Lu K; Guan W; Cao S; Ren M; Zhou C
    ChemMedChem; 2022 Jan; 17(2):e202100671. PubMed ID: 34807508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic GMP-AMP as an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA.
    Kato K; Omura H; Ishitani R; Nureki O
    Annu Rev Biochem; 2017 Jun; 86():541-566. PubMed ID: 28399655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A STING to inflammation and autoimmunity.
    Kumar V
    J Leukoc Biol; 2019 Jul; 106(1):171-185. PubMed ID: 30990921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The catalytic mechanism of cyclic GMP-AMP synthase (cGAS) and implications for innate immunity and inhibition.
    Hall J; Ralph EC; Shanker S; Wang H; Byrnes LJ; Horst R; Wong J; Brault A; Dumlao D; Smith JF; Dakin LA; Schmitt DC; Trujillo J; Vincent F; Griffor M; Aulabaugh AE
    Protein Sci; 2017 Dec; 26(12):2367-2380. PubMed ID: 28940468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cGAS-STING pathway as a therapeutic target in inflammatory diseases.
    Decout A; Katz JD; Venkatraman S; Ablasser A
    Nat Rev Immunol; 2021 Sep; 21(9):548-569. PubMed ID: 33833439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 Mediated Innate Immune Response.
    Li T; Cheng H; Yuan H; Xu Q; Shu C; Zhang Y; Xu P; Tan J; Rui Y; Li P; Tan X
    Sci Rep; 2016 Jan; 6():19049. PubMed ID: 26754564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING.
    Diner EJ; Burdette DL; Wilson SC; Monroe KM; Kellenberger CA; Hyodo M; Hayakawa Y; Hammond MC; Vance RE
    Cell Rep; 2013 May; 3(5):1355-61. PubMed ID: 23707065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second messenger 2'3'-cyclic GMP-AMP (2'3'-cGAMP): the cell autonomous and non-autonomous roles in cancer progression.
    Ma XY; Chen MM; Meng LH
    Acta Pharmacol Sin; 2024 May; 45(5):890-899. PubMed ID: 38177693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cGAS/cGAMP/STING signal propagation in the tumor microenvironment: Key role for myeloid cells in antitumor immunity.
    Mekers VE; Kho VM; Ansems M; Adema GJ
    Radiother Oncol; 2022 Sep; 174():158-167. PubMed ID: 35870728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The induction of inflammation by the cGAS-STING pathway in human dental pulp cells: A laboratory investigation.
    Tian X; Liu C; Wang Z
    Int Endod J; 2022 Jan; 55(1):54-63. PubMed ID: 34570917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonists and Inhibitors of the cGAS-STING Pathway.
    Yu X; Cai L; Yao J; Li C; Wang X
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38999073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the cGAS-cGAMP-STING Activity of Cancer Cells.
    Pépin G; Gantier MP
    Methods Mol Biol; 2018; 1725():257-266. PubMed ID: 29322423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response.
    Marcus A; Mao AJ; Lensink-Vasan M; Wang L; Vance RE; Raulet DH
    Immunity; 2018 Oct; 49(4):754-763.e4. PubMed ID: 30332631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic strategies for the evasion of cGAS-STING signaling-mediated immune surveillance in human cancer: How therapy can overcome them.
    Zou SS; Qiao Y; Zhu S; Gao B; Yang N; Liu YJ; Chen J
    Pharmacol Res; 2021 Apr; 166():105514. PubMed ID: 33631336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cGAS/STING Pathway: A Novel Target for Cancer Therapy.
    Gan Y; Li X; Han S; Liang Q; Ma X; Rong P; Wang W; Li W
    Front Immunol; 2021; 12():795401. PubMed ID: 35046953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of double-stranded DNA sensing through the cGAS-STING pathway.
    Shu C; Li X; Li P
    Cytokine Growth Factor Rev; 2014 Dec; 25(6):641-8. PubMed ID: 25007740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral and metazoan poxins are cGAMP-specific nucleases that restrict cGAS-STING signalling.
    Eaglesham JB; Pan Y; Kupper TS; Kranzusch PJ
    Nature; 2019 Feb; 566(7743):259-263. PubMed ID: 30728498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STING activation in cancer immunotherapy.
    Su T; Zhang Y; Valerie K; Wang XY; Lin S; Zhu G
    Theranostics; 2019; 9(25):7759-7771. PubMed ID: 31695799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms and cellular functions of cGAS-STING signalling.
    Hopfner KP; Hornung V
    Nat Rev Mol Cell Biol; 2020 Sep; 21(9):501-521. PubMed ID: 32424334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cGAS-cGAMP-STING Pathway: A Molecular Link Between Immunity and Metabolism.
    Bai J; Liu F
    Diabetes; 2019 Jun; 68(6):1099-1108. PubMed ID: 31109939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.